Posted by AGORACOM-Eric
at 10:32 AM on Monday, February 8th, 2021
The 3 Reasons Why Arctic Star Is A World Class, Small Cap Diamond Explorer
Arctic Star Exploration (ADD:TSXV / ASDZF:OTCQB / 82A1.F:FRA) is in the diamond finding business.
The Company owns 100% of its flagship Timantti Diamond Project in Finland, where Arctic Star has discovered three diamondiferous kimberlites that may represent the first finds in a large kimberlite field. If you don’t know what a kimberlite is, keep drilling down and see below because this is truly exciting.
The project is located on the same geological belt as the Grib Diamond Mine in Russia, just 450 kms away. The Grib mine is one of the largest diamond mines in the world and was discovered by a team led by Arctic Star Director Roy Spencer. Keep drilling down to see more about him.
For those investors who have a little more experience and find themselves asking Why Finland? You should know that Finland was ranked as the World’s #2 mining jurisdiction in the world by the Fraser Institute 2020. In addition to its flagship project in Finland, the Company also controls diamond exploration properties in Nunavut (Stein) and the Northwest Territories of Canada (Diagras and Redemption).
But the real secret of Arctic Star is that it has tremendous potential to revolutionize the way in which Diamonds are discovered – and become a pioneer in the exploration industry – by finding diamonds in a place where no previous explorer has thought to do so. More than just a wild theory, Arctic Star has the team to back it up.
Here are the 3 things you need to know
1. World Class Diamond Finders
Arctic Star exploration has a highly experienced diamond exploration team previously responsible for numerous world class diamond mine discoveries. The team is led by Buddy Doyle who originally discovered Diavik Mine, Canada’s largest diamond mine in terms of carat production. Diavik’s exceptional grades make it one of the most valuable diamond mines in the world. Diavik is located in the Northwest Territories of Canada, where Arctic Star has 2 of their diamond properties.
Few geologists have seen 2 projects from discovery through to decision to mine. Mr. Doyle is recognized by his peers in the exploration industry as an authority on diamond exploration and kimberlite geology, and has authored/co-authored numerous papers on these subjects. He was awarded the 2007 Hugo Dummitt Award for excellence in Diamond exploration.
Roy Spencer – If that wasn’t enough, the geologist who discovered the multi-billion-dollar Grib Diamond Mine in Russia (see above). which is just 450 KMs away from Arctic Star’s project in Finland, has now joined Arctic’s Board of Directors! Clearly, the Arctic Star team has the credibility necessary to put forth a new thesis on how to find diamonds.
2. Brand New Exploration Model To Find Diamonds
In order to find diamonds, you need to first find Kimberlites. What are Kimberlites? Essentially, they are the rocks which contain diamonds. These kimberlite rocks are found underground in vertical structures known as kimberlite pipes. To illustrate in simple terms, see this basic image of a kimberlite pipe with kimberlite rocks inside of it.
Kimberlite pipes are the biggest source of diamonds today. When exploration companies go looking for kimberlites, the industry standard for finding them is to look for magnetic signatures. This is done by taking a magnetic survey from the air and/or ground. with a device called a magnetometer. Now, most of you won’t understand what you are looking at – but here is an example of one of the company’s magnetic surveys on its Canadian Diagras property.
The most important thing to understand is that the industry looks for magnetic signatures ….. but Buddy Doyle and the accomplished Arctic Star team have developed a NON MAGNETIC THESIS. They believe they will find economic diamonds by locating Kimberlite that do not have a magnetic signature where previous explores sought not to look. Arctic in a sense is exploring for diamonds the opposite way the industry traditionally does. Arctic acquired property big mining company’s dropped, because they looked at them one way. Arctic is looking differently and success is occurring quickly for this small, yet accomplished exploration outfit. There are already multiple drill ready targets in 2 countries using this new way of looking for diamonds.
Arctic offers multiple opportunities in 2 countries to turn the Diamond Industry on notice with a discovery.
3. Arctic Star Has Two Diamond Projects Ready To Verify Its Non-Magnetic Theory
Arctic has 2 diamond projects on which to verify its theory: Diagras in Northwest Territories of Canada and Timantti in Finland, where early exploration searching for Non-Magnetic signatures has already yielded multiple new diamond target
A. Diagras is next to Diavik (Canada’s largest diamond mine) and is drill ready to prove Buddy’s theory. Arctic has plans to drill in 2021
B. Timantti in Finland has 3 separate target areas and 6 targets altogether identified through non-magnetic signatures as a means to find diamonds and further excel Buddy’s theory, it is the company’s goal to drill test in 2021
If Buddy Doyle and the Arctic Star team are correct it will create a new discovery process for understanding how diamonds are brought to surface in areas previous explorers cared not to look. Arctic Star has the potential to create multiple discoveries and copycat companies trying to duplicate their success.
However, there is only one Buddy Doyle and Roy Spencer, which is why Arctic Star is the one Diamond Exploration Company every investor should be aware of.
Posted by AGORACOM-JC
at 4:03 PM on Tuesday, January 12th, 2021
Else Nutrition Holdings Inc. (BABY: TSXV) (BABYF: OTCQX) (0YF: FSE) is the award winning, plant-based nutrition company for small cap investors. The shift towards plant-based alternatives has opened the food market to new players, and created an opportunity for fast growth in a rapidly expanding space.
Highlights include:
$CAD 30 Million In Cash
Launched 1st Commercial Product Into US Market
Backed By A $2.7 Billion Dollar Global Nutrition Company;
MOU For International Distribution Of Products
“Best Health” Award At Global Food Innovation Summit In Milan;
Awarded Patents In 22 Countries, 44 Countries Pending;
Executives & Advisors From Globally Renowned Companies & Institutions
Distribution agreement with one of the largest and most well regarded national fresh, organic and specialty food distributors in North America
Received key Clean Label Certifications for Toddler Nutrition Product
Posted by AGORACOM-Eric
at 12:37 PM on Thursday, January 7th, 2021
(CSE:XPHY / OTC:XPHYF / FSE:4XT)
Completed Successful SARS-CoV-2 RT-PCR Diagnostic Test Kit Validation
Secured Exclusive Psychedelic Drug Development Agreement
Appointed European Healthcare Executive to Board of Director
Engaged German Partner for Development of Psilocybin API Production
Announced Update on Contract Drug Delivery Program
Announced Update on Oral Thin Film Drug Delivery Program
Provided Update on Parkinson’s Transdermal Patch
Three Xphyto Divisions:
1. Vektor Pharma TF: World-class thin film drug delivery platforms for transdermal and oral dissolvable dosage forms
2. 3a-Diagnostics: Rapid, low-cost screening tests for pandemic and dental health applications
3. Xphyto Laboratories Inc.: Development of industrial production processes for emerging active pharmaceutical ingredients, including psychedelics and cannabinoid isolates
1. Vektor Pharma TF GmbH – Drug Delivery
100% owned XPhyto subsidiary
Global leader in design, testing and manufacture of therapeutic film drug delivery systems
Major pharma clients – past, present and future
Focused and nimble team – rapid turnaround on new opportunities
Versatile platform technology
Transdermal patches (TDS) – slow and steady release
Oral dissolvable film (ODF) sublingual strips – instant bioavailability
EU GMP facilities in Baden-Württemberg, Germany
Holder of numerous German narcotics import and manufacturing licences
XPhyto Drug Development Pipeline – Stage 1 & 2
Platform technology
Scalable product development pipeline
High-growth and new API opportunities
Neurological indications
Generic and hybrid-generic drug formulations
2. 3a-Diagnostics GmbH – Rapid Testing
XPhyto has an exclusive development, technology purchase and licence agreement
Specializing in the development, production, and marketing of low-cost point-of-care screening test systems:
COVID-19 rapid PCR Kit
COVID-19 disposable ultra-rapid test
Oral biosensors for the instant detection of bacterial and viral pathogens
Influenza A, H1N1 (swine flu), H5N1 (avian flu), Strep A, stomatitis, periimplantitis and periodontitis
Biosensor screening platform for high-throughput for identification of new biosensor targets for new biosensor products
Development partially funded by grants from the German Federal Ministry of Education and Research (BMBF)
As the name implies “PropTech” is a combination of two words and stands for “property technology.” As simple as that is, the implementation and importance of PropTech is anything but.
Like every other industry on the planet that is incorporating technology to create greater efficiencies and experiences, the commercial real estate market is no different and is seeing the rapid adoption of;
Artificial Intelligence
Machine learning
Big data
Internet of Things (IoT Sensors)
Cloud computing
To create cost savings by reducing and even eliminating existing costs, create greater efficiencies for the operation and maintenance of real estate assets, as well as, improve the design of new builds.
IMPACT OF COVID-19
The COVID-19 pandemic has served to significantly increased the demand for PropTech in the commercial real estate market as follows:
The need for solutions to get workers back into workplace buildings and offices. Specifically, the need to identify bacteria and viruses in indoor air quality, as well as, the ability to sanitize immediately and effectively.
The need to create even greater cost savings and efficiencies for real estate owners that will continue suffering losses until workers significantly return to the workplace.
WHY UNIVERSAL PROPTECH (UPI:TSXV)?
Whereas many companies are just now trying to capitalize on the opportunities presented in the current and massive future of PropTech, Universal PropTech Inc. (“UPI”) a diversified investment platform delivering healthy building solutions and services for building developers, owners and operators in Canada. More than just lip service, UPI has been successfully delivering its PropTech solutions for years, with revenues over the last 3 years as follows:
2017 – $13.8M
2018 – $13.7M
2019 – $15.9M
Headquartered in Toronto, UPI has offices across Canada including Halifax,Montreal, and Ottawa.
COMPANY HIGHLIGHTS
Used in Federal Government facilities for over 40 years
Provides real estate managers turnkey HVAC Building Controls design, equipment, installation and ongoing operations and maintenance services for Industrial, Commercial, Institutional and Multi-residential customers
Already possesses under-utilized IP in building controls to add in additional monitoring inputs and equipment controls
Diverse revenue streams via products, installations and ongoing
Key strategic partnerships afford the ability to monitor real-time utility meters, key BAS and systems data in a building.
Team has the capability to make sense of this data and apply advanced web tools to make recommendations to fine tune a building, saving from 5% to 15% of a facilities energy spend without capital expenditure
VCI offers the depth and breadth of Building Automation Systems (BAS) knowledge and products from the likes of Siemens and Honeywell to support building automation systems
As businesses return to the office, property managers must think about the design and safety of their buildings for occupants. Traditional cleaning methods are ineffective at preventing transmission. UV technology is able to sanitize all surfaces free from pathogens. UPI is capitalizing on this opportunity by building and acquiring UV technology as it is the best in the market to administer and integrate it into healthy buildings in Canada.
Posted by AGORACOM-JC
at 11:38 AM on Tuesday, December 15th, 2020
Innocan Pharma Corporation (INNO: CSE) (IP4:FSE) is developing the pharmaceutical guided missile to defeat coronavirus lung infections. The company specializes in the development of new drug platforms which combine unique properties of Cannabinoids.
3 Fully Operating Divisions For Investor Diversification
Innocan has 3 fully operating divisions to address the market for Cannabis products. As a Cannabis investor, why limit yourself to a Company with just one specialty, when Innocan offers you exposure to both the exploding world of cannabis pharma, as well as, a portfolio of patent-pending and launch ready consumer health products.
PHARMACEUTICAL – THE GUIDED MISSILE – Revolutionary technology targeting lungs infected with coronavirus or other viral infections.
CONSUMER RETAIL – DERMA COSMETICS – A premium derma cosmetics brand, manufacturing has commenced with distribution agreements in place.
OVER THE COUNTER (OTC) PRODUCTS FOR PAIN RELIEF – patent-pending CBD pain relief brand received FDA technical validation.
Global Manufacturing / Distribution Agreements
Endless Sky Inc. a Canadian large scale Cannabis extractor (Manufacturing and Distribution – Canada)
Active Therapeutics Ltd of Lancashire, United Kingdom (Distribution – UK and Ireland markets)
iAmHealth Distribution UG (Distribution – Germany)
Completed Trademark Registration in the EU, UK and Switzerland
Completion of the registration of its trademarks: Innocan Pharma, Relief & Go and SHIR in the EU, UK and Switzerland.
These trademarks represent Innocan’s OTC and derma cosmetic brand products that were recently launched in the German and UK markets.
Superior Management Team
In the small cap world, the jockey(s) that drive the horse are just as important as the horse itself. The InnoCan Leadership Group Is Incomparable In The Small Cap World, Comprised Of Leading Israeli Pharmaceutical Executives including:
Executive Chairman (Ron Mayron) was the CEO Of Teva Israel, one of the largest generic pharmaceutical companies in the world
Co-Founder & VP Business Development (Yoram Drucker) was the Founder of 2 NASDAQ Companies (Pluristem & Brainstorm)
Chief Technology Officer (Nir Avram) is a former member of the pharma innovation team at Perrigo, producer of OTC consumer goods and specialty pharma.
Chief Executive Officer (Iris Bincovich) has a proven track record in opening global markets, having managed hundreds of successful transactions in OTC, cosmetics and dermatology.
Together they have built one of the most formidable teams in the small cap cannabis world
Posted by AGORACOM-Eric
at 4:32 PM on Monday, December 14th, 2020
Fabled Silver Gold Corp. (TSXV: FCO)The Santa María Property is an under-explored, high-grade silver-gold project with significant exploration potential to expand mineral resources and identify new discoveries.
Fabled Silver Gold Company Highlights:
Commenced drilling on 100% option at Santa Maria Mine in Mexico
2020 NI 43-101 Resource of 3.2Moz Indicated and 1.1Moz Inferred in two primary veins
Two distinct Epithermal veins have been partially explored
Santa María Property is an under-explored, high-grade silver-gold project with significant exploration potential
19 significant vein structures exists within the property and provides future virgin exploration opportunities
Geophysical survey on the property and has successfully identified multiple targets for exploration and drilling
Santa Maria Deposit
High Grade silver-gold property located in mining friendly jurisdiction of Parrall, Mexico
The Parral mining district is situated in the center of the Mexican Silver belt, a district of epithermal silver gold mineralization
The belt has been recognized as producing more silver than any other equivalent are in the world
2018 PEA very supportive at current market prices
2 Mettalurgical Studies completed
Santa Maria vein structures provide many promising exploration and possibly future mining possibilities
The Santa Maria mine has never been systematically, or explored thoroughly with modern methods
The Asset: Santa Maria Mine 43-101
3.2Moz Indicated and 1.1Moz Inferred in two primary veins
High grade silver-gold property located in the mining friendly jurisdiction of Parrall, Chihuahua, Mexico.
The Parral mining district is situated in the centre of the Mexican silver belt epithermal silver-gold vein districts. The belt has been recognized as a significant metallogenic province, which has reportedly produced more silver than any other equivalent area in the world.
43-101 Technical Report completed on December 02, 2020 by Mineral Resources Engineering.
Significant vein structures within the property provides future exploration and mining opportunities.
